Submitted by Anonymous (not verified) on 16 October 2026 - 14:20
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 28, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 28, Status: Authorised